We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Staphylococcal Pathogens Assessed in Periprosthetic Joint Infections

By LabMedica International staff writers
Posted on 04 Nov 2016
Periprosthetic joint infections (PJI) are the main complication of knee and hip prosthetic arthroplasty and between 1% and 3% of patients undergoing prosthesis implantation are affected by these infections.

The characteristics of periprosthetic joint infection (PJI) due to Staphylococcus lugdunensis have been assessed and compared to the characteristics of PJI due to Staphylococcus aureus and Staphylococcus epidermidis. More...
S. lugdunensis is a coagulase-negative staphylococci (CoNS) that is considered part of the normal flora of human skin, as are other CoNS species.

Medical microbiologists at the Hôpital J. Ducuing (Toulouse, France) conducted a retrospective and descriptive study from 2000 to 2014, including patients from three orthopedic centers in the same area. Eighty-eight consecutive cases of monomicrobial staphylococcal PJI were analyzed; 28 due to S. lugdunensis, 30 to S. aureus, and 30 S. epidermidis. The diagnosis of PJI was established in the presence of one major criterion or two minor criteria: the major criteria were at least two positive periprosthetic cultures with phenotypically identical organisms, or a sinus tract communicating with the joint; minor criteria were a C-reactive protein (CRP) value greater than 10 mg/L and a histological analysis of periprosthetic tissue confirming a septic process.

For each suspected site, hard and soft tissue specimens were collected in sterile glass vials and articular fluid was inoculated into blood culture bottles. After inoculation into culture media, these were observed daily for microbial growth. Bacteriological criteria for a positive diagnosis of infection were the following: at least one positive sample for S. aureus-positive cultures; at least two positive samples for S. epidermidis- and S. lugdunensis-positive cultures. In the case of a positive culture, identification was performed by the Vitek 2 automated technique or the API Staph manual technique.

Clinical symptoms were more often reported in the S. lugdunensis group, and the median delay between surgery and infection was shorter for the S. lugdunensis group than for the S. aureus and S. epidermidis groups. As regards antibiotic susceptibility, the S. lugdunensis strains were susceptible to antibiotics and 61% of the patients could be treated with levofloxacin + rifampicin. The outcome of the PJI was favorable for 89% of patients with S. lugdunensis, 83% with S. aureus, and 97% with S. epidermidis. Nine unfavorable outcomes were reported in the total population.

The authors concluded that S. lugdunensis is classified as a CoNS, but the clinical features of S. lugdunensis PJI, the early aspect of the infection, and the relapses observed are similar to those in S. aureus PJI. Regarding the microbiological diagnosis, the species of CoNS in PJI must be identified precisely and treatment adapted to the antibiotic susceptibility, even if only one deep sample is positive in culture. The study was published in the October 2016 issue of the International Journal of Infectious Diseases.

Related Links:
Hôpital J. Ducuing



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.